Amedeo Smart

Free Medical Literature Service



Liver Diseases

  Free Subscription


1 Am J Pathol
1 Biochem Biophys Res Commun
2 BMC Cancer
3 BMC Gastroenterol
2 Br J Surg
1 Cancer Res
2 Dig Dis Sci
1 Endoscopy
1 Gastroenterology
3 Gut
16 Hepatology
1 Indian J Gastroenterol
1 J Clin Oncol
1 J Comput Assist Tomogr
1 J Gastroenterol Hepatol
20 J Hepatol
1 N Engl J Med
2 PLoS One
3 Radiology
1 Semin Liver Dis
1 Transplant Proc
1 Transplantation

    Am J Pathol

  1. ZHANG Y, Liu Y, Huo W, He L, et al
    The Role of miRNA and Long Noncoding RNA in Cholestatic Liver Diseases.
    Am J Pathol. 2024;194:879-893.
    >> Share

    Biochem Biophys Res Commun

  2. ZHANG S, Gao YF, Zhang K, Deng GR, et al
    Integrating network pharmacology and experimental validation reveals therapeutic effects of D-mannose on NAFLD through mTOR suppression.
    Biochem Biophys Res Commun. 2024;715:149999.
    >> Share

    BMC Cancer

  3. QIN Y, Tang C, Li J, Gong J, et al
    Liver cancer in China: the analysis of mortality and burden of disease trends from 2008 to 2021.
    BMC Cancer. 2024;24:594.
    >> Share

  4. XIAO Y, Deng W, Luo L, Zhu G, et al
    Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma.
    BMC Cancer. 2024;24:588.
    >> Share

    BMC Gastroenterol

  5. ZHANG Q, Yu T, Tan H, Shi H, et al
    Hepatic recruitment of myeloid-derived suppressor cells upon liver injury promotes both liver regeneration and fibrosis.
    BMC Gastroenterol. 2024;24:163.
    >> Share

  6. GUO Y, Dong S, Li M, Tao Y, et al
    A new model of portal vein thrombosis in rats with cirrhosis induced by partial portal vein ligation plus carbon tetrachloride and intervened with rivaroxaban.
    BMC Gastroenterol. 2024;24:161.
    >> Share

  7. CHEN X, Fu L, Zhu Z, Wang Y, et al
    Exploring the association between dietary fiber intake and hepatic steatosis: insights from NHANES.
    BMC Gastroenterol. 2024;24:160.
    >> Share

    Br J Surg

    Lesional liver biopsies: better treatments, better studies, better science.
    Br J Surg. 2024;111:znae063.
    >> Share

  9. DE GRAAFF MR, Hendriks TE, Wouters M, Nielen M, et al
    Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking.
    Br J Surg. 2024;111:znae119.
    >> Share

    Cancer Res

  10. RETTIG AR, Ganesh K
    Cancer Cells Hijack Physiologic Metabolic Signals to Seed Liver Metastasis.
    Cancer Res. 2024;84:1548-1549.
    >> Share

    Dig Dis Sci

  11. IM KH, Saeed WK, Kim EB, Lee AH, et al
    Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis.
    Dig Dis Sci. 2024;69:1701-1713.
    >> Share

  12. DONG Y, Xu H, Zhang Z, Zhou Z, et al
    A Novel Nomogram for Predicting Early Rebleeding After Endoscopic Treatment of Esophagogastric Variceal Hemorrhage.
    Dig Dis Sci. 2024;69:1852-1862.
    >> Share


  13. OGURA T, Okuda A, Ueno S, Nishioka N, et al
    Endoscopic ultrasound-guided hepaticogastrostomy stent exchange using a novel spiral plastic stent.
    Endoscopy. 2024;56.
    >> Share


  14. CHANG M, Hammami MB, Sakiani S
    A Case of Hepatobiliary Challenges: Unraveling the Mystery of Bile Duct Disappearance.
    Gastroenterology. 2024 May 14:S0016-5085(24)04914.
    >> Share


  15. WEN J, Zhang X, Wong CC, Zhang Y, et al
    Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma.
    Gut. 2024 May 13:gutjnl-2023-331117. doi: 10.1136/gutjnl-2023-331117.
    >> Share

  16. ISRAELSEN M, Alvarez-Silva C, Madsen BS, Hansen CD, et al
    Impact of acute alcohol consumption on circulating microbiome in asymptomatic alcohol-related liver disease.
    Gut. 2024;73:1041-1044.
    >> Share

  17. GEIER A, Trost J, Wang K, Schmid C, et al
    PNPLA3 fatty liver allele was fixed in Neanderthals and segregates neutrally in humans.
    Gut. 2024;73:1008-1014.
    >> Share


  18. AFONSO MB, Marques V, van Mil SWC, Rodrigues CMP, et al
    Human liver organoids: From generation to applications.
    Hepatology. 2024;79:1432-1451.
    >> Share

  19. JIN Y, Shou Y, Lei Q, Du C, et al
    An entropy weight method to integrate big omics and mechanistically evaluate DILI.
    Hepatology. 2024;79:1264-1278.
    >> Share

  20. WANG A, Blackford AL, Behling C, Wilson LA, et al
    Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease.
    Hepatology. 2024;79:1381-1392.
    >> Share

  21. UMBAUGH DS, Nguyen NT, Curry SC, Rule JA, et al
    The chemokine CXCL14 is a novel early prognostic biomarker for poor outcome in acetaminophen-induced acute liver failure.
    Hepatology. 2024;79:1352-1364.
    >> Share

  22. SIDALI S, Borie R, Sicre de Fontbrune F, El Husseini K, et al
    Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.
    Hepatology. 2024;79:1365-1380.
    >> Share

  23. SCHMIDT KA, Simonetto DA
    The telomere tango: Liver disease in the genomic spotlight.
    Hepatology. 2024;79:1249-1251.
    >> Share

  24. ZHAO G, Ma Q, Yang H, Jiang H, et al
    Base editing of the mutated TERT promoter inhibits liver tumor growth.
    Hepatology. 2024;79:1310-1323.
    >> Share

  25. ENGSTROM A, Wintzell V, Melbye M, Svanstrom H, et al
    Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study.
    Hepatology. 2024;79:1401-1411.
    >> Share

  26. ABDELMALEK MF, Rinella ME
    Steatotic liver disease, a useful construct in primary care that doesn't upset the apple cart.
    Hepatology. 2024;79:1252-1254.
    >> Share

  27. HANSEN BE, Vandriel SM, Vig P, Garner W, et al
    Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.
    Hepatology. 2024;79:1279-1292.
    >> Share

  28. YEH JG, Newsome PN
    Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study.
    Hepatology. 2024;79:1255-1257.
    >> Share

  29. CALZADILLA-BERTOT L, Jeffrey AW, Jeffrey GP
    Letter to the Editor: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Hepatology. 2024;79:E153-E154.
    >> Share

  30. LOMBARDI R, Dalbeni A, Mantovani A, Ravaioli F, et al
    Reply: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Hepatology. 2024;79:E155-E156.
    >> Share

  31. LI Z, Zhang Y, Li Y, Lan J, et al
    Letter to the Editor: Statins as potential confounding factors to investigate the association between the use of GLP-1 receptor agonists and risk of HCC.
    Hepatology. 2024;79:E169-E170.
    >> Share

  32. Hepatology Highlights.
    Hepatology. 2024;79:1239-1240.
    >> Share

  33. Erratum: Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.
    Hepatology. 2024;79:E171-E172.
    >> Share

    Indian J Gastroenterol

  34. KUMAR S, Irtaza M, Patra BR, Rao PK, et al
    Clinical profile of adult and pediatric patients with hepatic Wilson's disease.
    Indian J Gastroenterol. 2024 May 10. doi: 10.1007/s12664-024-01586.
    >> Share

    J Clin Oncol

  35. FICHTINGER RS, Aldrighetti LA, Abu Hilal M, Troisi RI, et al
    Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial.
    J Clin Oncol. 2024;42:1799-1809.
    >> Share

    J Comput Assist Tomogr

  36. DI STASIO M, Cordopatri C, Nardi C, Busoni S, et al
    Liver Biliary Function Evaluation on a 1.5T Magnetic Resonance Imaging Scan by T1 Reduction Rate Assessment Using Variable-Flip-Angle Sequences.
    J Comput Assist Tomogr. 2024;48:354-360.
    >> Share

    J Gastroenterol Hepatol

  37. LIU S, Gou H, Wei H, Chen S, et al
    Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell-mediated anti-hepatocellular carcinoma immunity.
    J Gastroenterol Hepatol. 2024 May 15. doi: 10.1111/jgh.16548.
    >> Share

    J Hepatol

  38. YANG M, Zhang F, Liu K
    Cirrhosis Decompensation: Clinical and Prognostic Analysis from a New Perspective.
    J Hepatol. 2024 May 9:S0168-8278(24)00337-4. doi: 10.1016/j.jhep.2024.
    >> Share

  39. ZHANG Y, Xiao F, Xie R
    Healthy volunteer bias for the role of genetic risk in dietary effects on hepatic steatosis, inflammation and fibrosis.
    J Hepatol. 2024 May 9:S0168-8278(24)00335-0. doi: 10.1016/j.jhep.2024.
    >> Share

  40. NARDELLI S, Vizzutti F, Marra F, Schepis F, et al
    Can we really advise a patient undergoing TIPS that the onset of episodic hepatic encephalopathy will not influence his/her survival?
    J Hepatol. 2024 May 9:S0168-8278(24)00339-8. doi: 10.1016/j.jhep.2024.
    >> Share

  41. ZHU CX, Yan K, Chen L, Huang RR, et al
    Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8(+) T cells in hepatocellular carcinoma.
    J Hepatol. 2024 May 15:S0168-8278(24)00342-8. doi: 10.1016/j.jhep.2024.
    >> Share

  42. VARGHESE J, Chapiro J
    ChatGPT: The transformative influence of generative AI on science and healthcare.
    J Hepatol. 2024;80:977-980.
    >> Share

  43. ZHANG Y, Liu H, Sheng B, Tham YC, et al
    Preliminary fatty liver disease grading using general-purpose online large language models: ChatGPT-4 or Bard?
    J Hepatol. 2024;80:e279-e281.
    >> Share

  44. KRUK B, Liebe R, Weber SN, Milkiewicz P, et al
    ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort.
    J Hepatol. 2023 Nov 28:S0168-8278(23)05290-X. doi: 10.1016/j.jhep.2023.
    >> Share

  45. HE C, Lu D, Zheng S, Xu X, et al
    Liver disease is a significant risk factor for cardiovascular outcomes - A UK Biobank study.
    J Hepatol. 2024;80:e287-e288.
    >> Share

  46. HAHN M, Herber A, Berg T, Seehofer D, et al
    Enhancing HCC Recurrence Prediction after Liver Transplantation: from DCP plus AFP-L3 model to GALAD Score.
    J Hepatol. 2023 Dec 16:S0168-8278(23)05357-6. doi: 10.1016/j.jhep.2023.
    >> Share

  47. PANG Y, Aberg F, Chen Z, Li L, et al
    Predicting risk of chronic liver disease in Chinese adults: External validation of the CLivD score.
    J Hepatol. 2024;80:e264-e266.
    >> Share

  48. COLAPIETRO F, Akpinar R, Pugliese N, Di Tommaso L, et al
    Unexpected diagnosis in females with abnormal liver ultrasound.
    J Hepatol. 2024;80:e243-e245.
    >> Share

  49. DUIJZER R, Boerrigter MM, Gevers TJG, Drenth JPH, et al
    The pathophysiology of polycystic liver disease.
    J Hepatol. 2024;80:981-983.
    >> Share

  50. BROUWERS MCGJ, Cassiman D
    Rare monogenic causes of steatotic liver disease masquerading as MASLD.
    J Hepatol. 2024;80:e252-e253.
    >> Share

  51. HASHIDA R, Nakano D, Kawaguchi M, Younossi ZM, et al
    Changing from NAFLD to MASLD: The implications for health-related quality of life data.
    J Hepatol. 2024;80:e249-e251.
    >> Share

  52. NORMAN JS, Mehta N
    Reply to: "Enhancing HCC recurrence prediction after liver transplantation: From DCP plus AFP-L3 model to GALAD score".
    J Hepatol. 2024;80:e273-e274.
    >> Share

  53. DAI H, Zhu C, Huai Q, Xu W, et al
    Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models.
    J Hepatol. 2024;80:913-927.
    >> Share

  54. WU XN, Wang MZ, Zhang N, Zhang W, et al
    Sex-determining region Y gene promotes liver fibrosis and accounts for sexual dimorphism in its pathophysiology.
    J Hepatol. 2024;80:928-940.
    >> Share

  55. ZOU Z, Liu X, Yu J, Ban T, et al
    Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.
    J Hepatol. 2024;80:834-845.
    >> Share

  56. CABIBBO G, Celsa C, Rimassa L, Torres F, et al
    Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice.
    J Hepatol. 2024;80:957-966.
    >> Share

  57. TANG R, Li Y, Chen R, Ma X, et al
    Reply to "ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort".
    J Hepatol. 2024 Jan 30:S0168-8278(24)00058-8. doi: 10.1016/j.jhep.2024.
    >> Share

    N Engl J Med

  58. NAJEM M, Dong E
    Esophageal Varices, White-Nipple Sign, and Portal Hypertensive Gastropathy.
    N Engl J Med. 2024;390:e47.
    >> Share

    PLoS One

  59. VATSYAYAN A, Kumar M, Saikia BJ, Scaria V, et al
    WilsonGenAI a deep learning approach to classify pathogenic variants in Wilson Disease.
    PLoS One. 2024;19:e0303787.
    >> Share

  60. OSAWA Y, Kawai H, Nakashima K, Nakaseko Y, et al
    Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis.
    PLoS One. 2024;19:e0303296.
    >> Share


  61. MENDIRATTA-LALA M, Fetzer D, Kamaya A, Parikh ND, et al
    The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance.
    Radiology. 2024;311:e232624.
    >> Share

  62. OZKAYA E, Kennedy P, Chen J, Bane O, et al
    Precision and Test-Retest Repeatability of Stiffness Measurement with MR Elastography: A Multicenter Phantom Study.
    Radiology. 2024;311:e233136.
    >> Share

  63. TANG A
    Liver Stiffness at MR Elastography: A Surrogate Biomarker for Staging Liver Fibrosis, Predicting Clinical Outcomes, and Selecting Patients.
    Radiology. 2024;311:e240890.
    >> Share

    Semin Liver Dis

  64. MA J, Bjornsson ES, Chalasani N
    Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment.
    Semin Liver Dis. 2024 May 13. doi: 10.1055/s-0044-1787062.
    >> Share

    Transplant Proc

  65. SILVA MS, Waisberg DR, Caldas TG, Martino RB, et al
    Life-Threatening Ruptured Hepatic Artery Pseudoaneurysm Post-Liver Transplant: A Case Report.
    Transplant Proc. 2024 May 13:S0041-1345(24)00256.
    >> Share


  66. CILLO U, Lauterio A, Furlanetto A, Canitano N, et al
    Full-left/Full-right Liver Splitting With Middle Hepatic Vein and Caval Partition During Dual Hypothermic Oxygenated Machine Perfusion.
    Transplantation. 2024 May 17. doi: 10.1097/TP.0000000000005039.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016